[Helicobacter pylori and distal gastric adenocarcinoma: Did we underestimate the pathogenic importance of the bacterium?].
Jüttner
S
S
Medizinische Klinik mit Schwerpunkt Hepatologie, Gastroenterologie, Endokrinologie und Stoffwechsel, Universitätsklinikum Charité, Campus Virchow-Klinikum, Humboldt-Universität, Berlin, Germany.
Höcker
M
M
D000230:Adenocarcinoma / Q000209:etiology* / Q000517:prevention & control; D000367:Age Factors; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D016017:Odds Ratio; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors